Blackrock Financial Management has reported a short position equivalent to 0.50 percent of the capital in Danish pharmaceutical company Zealand Pharma. The firm is thereby a disclosed short seller in the company.
The Danish Financial Supervisory Authority requires positions above 0.1 percent to be reported and short positions above 0.5 percent to be made public.
